Researcher
Claus Bachert
- Disciplines:Allergology
Affiliations
- Department of Head and Skin (Department)
Member
From1 Oct 2018 → 30 Sep 2022 - Department of Otorhinolaryngology (Department)
Member
From1 Oct 1998 → 30 Sep 2018
Projects
1 - 10 of 31
- Role of IL-33 and SERPINB4 in the exacerbations of airway inflammation, induced by viral- or bacterial-derived pathogensFrom1 Nov 2019 → TodayFunding: FWO Strategic Basic Research Grant
- Protease dependent regulation of IL-33 activity in allergic airway inflammationFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project
- Understanding Heterogeneity of Eosinophils in Airway DiseaseFrom1 Jan 2018 → 31 Dec 2021Funding: FWO EOS
- Eosinophils in upper airway inflammation : the good, the bad or the ugly? A study on the role of staphylococcus aureus in the interactions and plasticity of eosinophils and their products in upper airway inflammation.From1 Oct 2017 → 29 Feb 2020Funding: FWO fellowships
- Investigation of the role and interaction of eosinophil extracellular traps and Staphylococcus Aureus in chronic rhinosinusitisFrom1 Jan 2016 → 31 Dec 2018Funding: FWO research project
- Peroxisomes in mast cells – their functions and link to airway inflammationFrom1 Oct 2014 → 30 Sep 2018Funding: FWO fellowships, BOF - Other initiatives
- Identification of immunomodulating factors affecting T cell plasticity in upper airwaysFrom1 Mar 2014 → 30 Nov 2016Funding: BOF - Other initiatives
- The role of peroxisomes in inflammation and cell deathFrom1 Jan 2014 → 31 Oct 2019Funding: BOF - Concerted Research Project from 1994
- Role of purinergic signaling in the pathophysiology of human chronic upper airway inflammationFrom1 Sep 2013 → 28 Feb 2014Funding: BOF - Doctoral projects
- S100A8/A9, HMGB1 and their common receptors in the pathophysiology of human chronic airway inflammationFrom1 Mar 2013 → 31 Dec 2017Funding: BOF - Doctoral projects
Publications
1 - 10 of 668
- Effects of biologics treatment in type 2-high chronic rhinosinusitis with nasal polyp patients(2023)Volume: 151
Authors: Sharon Van Nevel, Tim Meese, Gabriële Holtappels, Natalie De Ruyck, Stijn Vanhee, Nan Zhang, Filip Van Nieuwerburgh, Claus Bachert
Pages: AB187 - AB187 - Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors(2023)
Authors: Xiangdong Wang, Yutong Sima, Yan Zhao, Nan Zhang, Ming Zheng, Kun Du, Min Wang, Yue Wang, Yun Hao, Ying Li, et al.
Pages: 458 - 468 - Differential protease content of mast cells and the processing of IL-33 in Alternaria alternata induced allergic airway inflammation in mice(2023)
Authors: Olga Krysko, Darya Korsakova, Andrea Renate Teufelberger, Amse De Meyer, Jill Steels, Natalie De Ruyck, Judith van Ovost, Sharon Van Nevel, Gabriële Holtappels, Frauke Coppieters, et al.
- Respiratory infections and anti-infective medication use from phase 3 dupilumab respiratory studies(2022)
Authors: Bob Geng, Claus Bachert, William W. Busse, Philippe Gevaert, Stella E. Lee, Michael S. Niederman, Zhen Chen, Xin Lu, Faisal A. Khokhar, Upender Kapoor, et al.
Pages: 732 - 741 - A diagnostic model for predicting type 2 nasal polyps using biomarkers in nasal secretion(2022)
Authors: Zaichuan Wang, Qiqi Wang, Su Duan, Yuling Zhang, Limin Zhao, Shujian Zhang, Liusiqi Hao, Yan Li, Xiangdong Wang, Chenshuo Wang, et al.
- Symptom free days in patients with severe chronic rhinosinusitis with nasal polyps treated with dupilumab(2022)Volume: 149
Authors: Claus Bachert, Claire Hopkins, Joseph Han, Wytske Fokkens, Leda Mannent, Asif Hameed Khan, Jérôme Msihid, Urvi Mujumdar, Siddhesh Kamat, Scott Nash, et al.
Pages: AB143 - AB143 - Evaluating treatment responses of dupilumab versus omalizumab in type 2 patients : the EVEREST trial(2022)Volume: 149
Authors: Lucia de Prado Gomez, Asif Hameed Khan, Anju Peters, Claus Bachert, Martin Wagenmann, Enrico Heffler, Claire Hopkins, Peter Hellings, Mei Zhang, Jun Xing, et al.
Pages: AB49 - AB49 - Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation(2022)
Authors: Olga Krysko, Joshua H. Bourne, Elena Kondakova, Elena A. Galova, Katharine Whitworth, Maddy L. Newby, Claus Bachert, Harriet Hill, Max Crispin, Zania Stamataki, et al.
- Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial(2022)
Authors: Claus Bachert, Joseph K. Han, Martin Y. Desrosiers, Philippe Gevaert, Enrico Heffler, Claire Hopkins, Jody R. Tversky, Peter Barker, David Cohen, Claire Emson, et al.
Pages: 1309 - 1317.e12 - Advances in chronic rhinosinusitis in 2020 and 2021(2022)
Authors: Zhaofeng Xu, Yanran Huang, Tim Delemarre, Carlo Cavaliere, Nan Zhang, Claus Bachert
Pages: 854 - 866